Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action.

Aleen Khoury, Krishant M Deo, Janice R Aldrich-Wright

Journal of inorganic biochemistry 2020 Jun

filter terms:

Current platinum-based drugs used in chemotherapy, like cisplatin and its derivatives, are greatly limited due to side-effects and drug resistance. This has inspired the search for novel platinum-based drugs that deviate from the conventional mechanism of action seen with current chemotherapeutics. This review highlights recent advances in platinum(II) and platinum(IV)-based complexes that have been developed within the past six years. The platinum compounds explored within this review are those that display a more targeted approach by incorporating ligands that act on selected cellular targets within cancer cells. This includes mitochondria, overexpressed receptors or proteins and enzymes that contribute to cancer cell proliferation. These types of platinum compounds have shown significant improvements in anticancer activity and as such, this review highlights the importance of pursuing these new designed platinum drugs for cancer therapy, with the potential of undergoing clinical trials. Copyright © 2020. Published by Elsevier Inc.

Citation

Aleen Khoury, Krishant M Deo, Janice R Aldrich-Wright. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. Journal of inorganic biochemistry. 2020 Jun;207:111070